INS and type 2 diabetes mellitus: The study by Casell et al. showed that medical devices (e.g., infusion sets, haemodialysis needles and tubes) can be a detectable source of microplastics (MP) but concluded that the higher burden in patients with type 2 diabetes cannot be explained solely by the iatrogenic effects of pens/insulin.